Security record · archived quarter
IBRX
ImmunityBio, Inc. · Healthcare · Biotechnology
8Tracked holders
0Δ holders
12.96MShares held
$39.01MReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -9.2% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | +5 | 153.88M | $1.35B | +10 | −5 |
| Q1 2026 | 103 | +11 | 130.83M | $998.92M | +19 | −8 |
| Q4 2025 | 91 | -1 | 143.54M | $283.94M | — | −1 |
| Q3 2025 | 15 | 0 | 77.60M | $190.89M | +2 | −2 |
| Q2 2025 | 12 | +1 | 58.35M | $154.05M | +1 | — |
| Q1 2025 | 8 | 0 | 12.96M | $39.01M | +1 | −1 |
| Q4 2024 | 8 | +1 | 14.27M | $36.54M | +2 | −1 |
| Q3 2024 | 6 | 0 | 5.93M | $22.06M | +1 | −1 |
| Q2 2024 | 6 | — | 4.42M | $27.95M | — | — |
Who holds it · Q1 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 7.58M | -22.5% | $22.83M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 4.29M | +11.7% | $12.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 4.29M | +11.7% | $12.91M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 478.32K | +566.6% | $1.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 478.32K | +566.6% | $1.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Millennium Management ✦ | 429.75K | +83.6% | $1.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 66.10K | +17.4% | $199,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Gotham Asset Management ✦ | 45.01K | New | $135,465 | 0.0% | New | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 44.45K | +193.4% | $133,788 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 44.45K | +193.4% | $133,788 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 44.45K | +193.4% | $133,788 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 44.45K | +193.4% | $133,788 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 44.45K | +193.4% | $133,788 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 23.80K | -15.9% | $71,638 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Gotham Asset Management | $135,465 | 0.0% |
Exited
| Marshall Wace | $615,197 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 383 holders, 176.43M shares, $1.31B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q1 2025 ·
Methodology ·
Get this via the API